Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, 100029, Beijing, China.
Department of Cardiovascular Surgery, Beijing Aortic Disease Center, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Disease, 100029, Beijing, China.
Asian J Surg. 2021 Jan;44(1):87-92. doi: 10.1016/j.asjsur.2020.03.014. Epub 2020 Apr 30.
Cardiac reoperation has always been a difficult problem in clinical practice. Because of the difficulty of operation, the incidence of complications and mortality rate is high. Secondary aortic surgery, especially the reoperation involving arch, has higher risk and is more difficult for patients with renal failure. Sun's operation (total arch replacement + stent elephant nose) has achieved good results in the treatment of diseases involving aortic arch, and occupies an important position in the treatment of patients with secondary arch lesions after cardiac surgery.
A total of 395 patients with a history of cardiac surgery were recorded in our center from January 1, 2009 to December 31, 2017, among whom 118 (30.1%) patients underwent aortic reoperation via the original incision using Sun's aortic procedure owing to postoperative great vessel disease. We analyzed the clinical data and survival time, and used Cox regression to analyze the risk factors for 30-day mortality as well as long term mortality.
The interval between the last operation and the present operation was 0.08-19 years. Sixteen patients died within 30 days after operation and the average mortality rate was 13.6%. During the follow-up period, 28 patients died, with the mortality rate of 23.7%. As of December 31, 2017, the longest survival time was 9.36 years, and the survival time of 70 patients was more than 3.05 years. The main risk factor associated with the 30-day survival was cardiopulmonary bypass (CPB) time. The longer the CPB time was, the greater the risk of death was. The main risk factors associated with the long-term survival were CPB time and 24-h bleeding volume. The longer the CPB time was, the more the 24-h bleeding volume was, the higher long-term mortality rate was.
The second Sun's operation, as a surgical treatment after cardiac surgery, showed a high survival rate, with long survival time and good curative effect. CPB is the main risk factor for the 30-day survival state after operation, and CPB time and 24-h bleeding volume are the main risk factors for the long-term survival state after operation.
心脏再次手术一直是临床实践中的难题。由于手术难度大,并发症发生率和死亡率高。再次主动脉手术,特别是涉及弓部的再次手术,对肾衰竭患者风险更高,难度更大。孙逸仙手术(全主动脉弓置换+支架象鼻)在治疗主动脉弓疾病方面取得了良好的效果,在心脏手术后再次出现弓部病变患者的治疗中占有重要地位。
本中心 2009 年 1 月 1 日至 2017 年 12 月 31 日共记录 395 例心脏手术后患者,其中 118 例(30.1%)因术后大血管病变,经原切口行主动脉再次手术,采用孙逸仙手术。分析临床资料及生存时间,采用 Cox 回归分析 30 天死亡率及长期死亡率的危险因素。
末次手术至本次手术的间隔时间为 0.08-19 年。术后 30 天内死亡 16 例,平均死亡率为 13.6%。随访期间死亡 28 例,死亡率为 23.7%。截至 2017 年 12 月 31 日,最长生存时间为 9.36 年,70 例患者生存时间大于 3.05 年。与 30 天生存相关的主要危险因素是体外循环(CPB)时间,CPB 时间越长,死亡风险越大。与长期生存相关的主要危险因素是 CPB 时间和 24 h 出血量,CPB 时间越长,24 h 出血量越大,长期死亡率越高。
心脏手术后再次行孙逸仙手术作为一种外科治疗方法,具有较高的生存率,生存时间长,疗效好。CPB 是术后 30 天生存状态的主要危险因素,CPB 时间和 24 h 出血量是术后长期生存状态的主要危险因素。